Stoke Therapeutics (STOK)RTW Investments, LP added to its stake +77K shares

5.62M

Shares reported · +77K vs prior quarter

1.8%

Disclosed portfolio weight

$183M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 23, 2026Company filing · Form 8-K · Auditor changeChanged its auditor“On March 23, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of Stoke Therapeutics, Inc. (the “Company”) dismissed KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm.”
2. Apr 3, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 3, 2026, the Board of Directors (the “Board”) of Stoke Therapeutics, Inc. (“Stoke” or the “Company”), increased the size of the Board to ten (10) directors and, following the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed G. Clare Kahn, Ph.D. to serve on the Board as a Class I director, effective immediately, to fill the vacancy created by the increase in Board…”
3. May 7, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Aug 3, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Stoke Therapeutics

For Stoke Therapeutics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STOK page.

How this filing works

• SEC Form 13F

Other disclosures at Stoke Therapeutics

• SEC Form 144Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 13F-HRMay 14, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRFeb 17, 2026

Everything OQRO holds on this company is on its STOK page.